The clinical progress of
H. pylori infection is determined by several virulence factors that might forecast the risk for symptomatic clinical results. The attachment of
H. pylori to epithelial cells is an appropriate step in explicit tropism and in developing gastraduodenal pathologies and persistency of infection (
12).
BabA2 protein attaches
H. pylori to the blood group antigen Lewis-b existing on the surface of human gastric epithelial cells (
3). In the present study, we determined the frequency of
babA2 and
hpa in 80
H. pylori isolates from selected patients with functional dyspepsia. In the current study, the
babA2 gene was found in 40% of gastric biopsies; this frequency was higher than
babA2 reported by Paniagua et al. (21.7%) and lower than Boria et al. (82.3%) and Safaei et al. (71.6%) (
13,
14).
Numerous documents revealed that
H. pylori expression
babA are related to more severe mucosal cellular inflammation and increased risk of clinical outcome diseases like active gastritis, peptic ulcer, and gastric cancer (
15). The study of Cadamuro et al. revealed that occurrence of
babA was significantly associated with duodenal ulcer and adenocarcinoma and would be a useful marker to identify patients who are at higher risk for
H. pylori-related diseases (
15). Mizushima et al. found that
babA prevalence in Japan is higher than the Western countries. They detected the
babA gene in 85% of their local isolates, while the rate is about 66% to 72% for the Western countries. No significant relationship was found between the
babA2 genotype and the clinical outcomes (
16). However, in our study,
babA gene was detected in 51% of the isolates, and no association was found between the
babA gene and gastraduodenal disease.
Helicobacter pylori adhesion A (
hpaA), which is a conserved surface lipoprotein and is essential for colonization of
H. pylori, can induce immune responses and produce anti-bodies against
HpaA in humans. Furthermore, this protein is a promising vaccine candidate against
H. pylori infection (
17).
Hpa is a strong colonization factor for
H. pylori. In this study, we determined the frequency of the
hpa genotype in 80
H. pylori isolates from patients with peptic ulcer or gastric adenocarcinoma. Therefore, it is difficult to explain different clinical outcomes only from virulence factors such as
babA2,
hpa of
H. pylori. The
hpa gene was found to be present in 27.5% of
babA2-negative strains. In our study, the prevalence of
hpa genotype was 71.2%, it was 31.2% in gastritis, 27.5% in peptic ulcer, and 12.5% in gastric cancer. Furthermore, in this study, no relationship was found between presence of
babA and
hpa genes and gastric disease. However, other studies have found a strong association between the occurrence of
babA2 gene and DU disease.